ClinicalTrials.Veeva

Menu

Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Unknown
Early Phase 1

Conditions

Missed Abortion

Treatments

Drug: Misoprostol Pill

Study type

Interventional

Funder types

Other

Identifiers

NCT05001061
Misoprostol abortion

Details and patient eligibility

About

Efficacy of sublingual versus vaginal misoprostol in termination of first trimester missed abortion

Full description

study will be made on female patients with first trimester missed abortion confirmed by ultrasound . Participants will be divided into 2 groups one group (A) will receive sublingual Misoprostol and the other group(B) will receive vaginal Misoprostol as a 800 micro grams every 4 hours in both groups up to five doses the aim of the study is to compare efficay of sublingual and vaginal Misoprostol in complete termination of first trimester missed abortion and which route is the best will less side effects.

Enrollment

288 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women with an ultrasound diagnosis of missed abortion < 13 weeks gestation without any clinical criteria of Inevitable abortion.

Exclusion criteria

  • Patients refused the medical treatment.
  • Patients have contraindications of the drug (Misoprostol).
  • Missed abortion associated with any signs of sepsis

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

288 participants in 2 patient groups

Sublingual Misoprostol for termination of first trimester missed abortion
Active Comparator group
Description:
Patients diagnosed as first trimester missed abortion will receive sublingual Misoprostol 800 micrograms every 4 hours up to five doses
Treatment:
Drug: Misoprostol Pill
Vaginal Misoprostol for termination of first trimester missed abortion
Active Comparator group
Description:
Patients diagnosed as first trimester missed abortion will receive vaginal Misoprostol 800 micrograms every 4 hours up to five doses
Treatment:
Drug: Misoprostol Pill

Trial contacts and locations

0

Loading...

Central trial contact

Ahmed Emam

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems